Details

---

Manufacturer
GLAXOSMITHKLINE PHARMACEUTICALS SA
 
Contents
Abacavir 600 mg, lamivudine 300 mg
 
Indication
HIV infection.
 
Instruction
May be taken with or without food.
 
Drug interaction
Abacavir: Decreased plasma conc w/ rifampicin, phenobarb, phenytoin. Decreased C_max w/ methadone. Lamivudine: Increased AUC w/ co-trimoxazole, ethanol. Inhibited intracellular phosphorylation of cladribine.